Search research articles
Contact Us
Filters
Showing results (301-310 of 340) with videos related to
Page
of 34
Sort By:
JAMA Neurology
|
February 23, 2026
Dietary Patterns and Indicators of Cognitive Function
Hui Chen, Marianna Cortese, Mario H Flores-Torres, et al.
Journal of Parkinson'S Disease
|
April 7, 2020
Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study
Rachit Bakshi, Eric A Macklin, Albert Y Hung, et al.
Neurology
|
October 1, 2020
Association of caffeine and related analytes with resistance to Parkinson disease among <i>LRRK2</i> mutation carriers: A metabolomic study
Grace F Crotty, Romeo Maciuca, Eric A Macklin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
Bernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 28, 2020
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis
Kjetil Bjornevik, Éilis J O'Reilly, Marianna Cortese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 26, 2026
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years
Xiaojing Peng, Kjetil Bjornevik, Clary B Clish, et al.
Nature Communications
|
June 22, 2026
Persistence of memory: lifespan dynamics of the human antiviral antibody reactome
Moriah M Mitchell, Tomasz Kula, Jennifer L Remmel, et al.
Ebiomedicine
|
November 13, 2018
Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease
Xiqun Chen, Chizoba C Umeh, Robert E Tainsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 7, 2022
Body mass index as a predictor of MS activity and progression among participants in BENEFIT
Juan Manuel Escobar, Marianna Cortese, Gilles Edan, et al.
Neurology
|
October 11, 2015
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT
Kassandra L Munger, Kathryn C Fitzgerald, Mark S Freedman, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 340) with videos related to
Sort By:
Page
of 34
JAMA Neurology
|
February 23, 2026
Dietary Patterns and Indicators of Cognitive Function
Hui Chen, Marianna Cortese, Mario H Flores-Torres, et al.
Journal of Parkinson'S Disease
|
April 7, 2020
Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study
Rachit Bakshi, Eric A Macklin, Albert Y Hung, et al.
Neurology
|
October 1, 2020
Association of caffeine and related analytes with resistance to Parkinson disease among <i>LRRK2</i> mutation carriers: A metabolomic study
Grace F Crotty, Romeo Maciuca, Eric A Macklin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
Bernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 28, 2020
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis
Kjetil Bjornevik, Éilis J O'Reilly, Marianna Cortese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 26, 2026
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years
Xiaojing Peng, Kjetil Bjornevik, Clary B Clish, et al.
Nature Communications
|
June 22, 2026
Persistence of memory: lifespan dynamics of the human antiviral antibody reactome
Moriah M Mitchell, Tomasz Kula, Jennifer L Remmel, et al.
Ebiomedicine
|
November 13, 2018
Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease
Xiqun Chen, Chizoba C Umeh, Robert E Tainsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 7, 2022
Body mass index as a predictor of MS activity and progression among participants in BENEFIT
Juan Manuel Escobar, Marianna Cortese, Gilles Edan, et al.
Neurology
|
October 11, 2015
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT
Kassandra L Munger, Kathryn C Fitzgerald, Mark S Freedman, et al.
Page
of 34